As Chief Medical Officer, I bring 25 years of experience leading clinical teams across the full spectrum of drug development—from early preclinical research through registrational studies. My deep expertise in oncology is matched by a steadfast commitment to advancing innovative therapies that improve patient outcomes. Throughout my career, I have partnered with scientists, clinicians, and regulators to translate groundbreaking science into meaningful treatments, always with patients at the heart of every decision. I believe the greatest impact comes when rigorous science and compassionate care meet, and my mission is to ensure that promising therapies reach the people who need them most.